Search

Daemian D Dussault

from Auburndale, MA
Age ~51

Daemian Dussault Phones & Addresses

  • 49 Prairie Ave, Auburndale, MA 02466
  • Washington, DC
  • Lowell, MA
  • Woburn, MA
  • Melrose, MA
  • Bedford, MA
  • Cambridge, MA
  • Las Vegas, NV
  • 5 Chestnut St APT 4, Woburn, MA 01801 (781) 275-0620

Work

Company: Astrazeneca - Waltham, MA Jan 2005 Position: Senior associate scientist

Education

School / High School: Massachusetts Institute of Technology- Cambridge, MA Dec 2004 Specialities: Master of Science in chemistry

Resumes

Resumes

Daemian Dussault Photo 1

Experienced Medicinal-Synthetic-Analytical Chemist, Looking For A Good Fit.

View page
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Education:
Massachusetts Institute of Technology 2003 - 2004
M.S., organic chemistry
University of Massachusetts Boston 2000 - 2003
B.S., chemistry
Skills:
Parallel synthesis
Drug discovery
LC-MS
Organic synthesis
Multi-step, linear synthesis
NMR
Characterization
Normal-phase chromatography
Reverse-phase separations
Purification
Structure elucidation
Multi-step, modular synthesis
Methodology
GC-MS
Daemian Dussault Photo 2

Chemistry

View page
Location:
134 Willard St, Lowell, MA 01850
Industry:
Research
Work:
Q-State Biosciences
Chemistry

Curadel, Llc
Scientist Iii
Education:
University of Massachusetts Lowell 2013 - 2014
Massachusetts Institute of Technology 2003 - 2004
Master of Science, Masters, Organic Chemistry
University of Massachusetts Boston 2000 - 2003
Bachelors, Bachelor of Science, Chemistry
Classical High School
University of Nevada, Las Vegas
University of Nevada, Reno
Massachusetts Institute of Technology
Masters, Chemistry
Skills:
Lc Ms
Nmr
Organic Synthesis
Purification
Chemistry
Drug Discovery
Characterization
Chromatography
Analytical Chemistry
Drug Design
Parallel Synthesis
Pharmaceutical Industry
Structure Elucidation
Hplc
Normal Phase Chromatography
Reverse Phase Separations
Methodology
Gc Ms
High Performance Liquid Chromatography
Nuclear Magnetic Resonance
Daemian Dussault Photo 3

Daemian Dussault Melrose, MA

View page
Work:
AstraZeneca
Waltham, MA
Jan 2005 to Apr 2012
Senior Associate Scientist

Education:
Massachusetts Institute of Technology
Cambridge, MA
Dec 2004
Master of Science in chemistry

University of Massachusetts
Boston, MA
May 2003
Bachelor of Science

Publications

Us Patents

Heterocyclic Derivatives And Methods Of Use Thereof

View page
US Patent:
20100137313, Jun 3, 2010
Filed:
Oct 2, 2009
Appl. No.:
12/572436
Inventors:
Daniel Robert Carcanague - Waltham MA, US
Daemian David Dussault - Waltham MA, US
Holia Hatoum-Mokdad - Waltham MA, US
Kenneth Gregory Hull - Waltham MA, US
Georgine Ioannidis - Waltham MA, US
John Irvin Manchester - Waltham MA, US
Helen Maureen McGuire - Waltham MA, US
David Charles McKinney - Waltham MA, US
Suzanne Stokes - Waltham MA, US
International Classification:
A61K 31/5377
C07D 401/14
A61K 31/506
C07D 413/14
US Classification:
5142365, 544331, 514275, 544122
Abstract:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

Beta-Lactamase Inhibitor Compounds

View page
US Patent:
20160175290, Jun 23, 2016
Filed:
Feb 29, 2016
Appl. No.:
15/056090
Inventors:
- London, GB
Shanta Bist - Nashua NH, US
Neil Bifulco - Sudbury MA, US
Liang Zhao - Lexington MA, US
Ye Wu - Waltham MA, US
Hoan Huynh - Waltham MA, US
Hui Xiong - Chesterbrook PA, US
Janelle Comita-Prevoir - Northborough MA, US
Daemian Dussault - Lowell MA, US
Bolin Geng - Andover MA, US
Brendan Chen - Sudbury MA, US
Thomas Francois Durand-Reville - Belmont MA, US
Satenig Guler - Waltham MA, US
International Classification:
A61K 31/439
A61K 31/546
A61K 31/407
A61K 31/4545
A61K 31/43
A61K 31/427
A61K 31/675
A61K 31/444
C07D 471/08
A61K 31/496
Abstract:
The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia):or a pharmaceutically acceptable salt thereof, wherein the values of R, R, Rand Rare described herein.

Beta-Lactamase Inhibitor Compounds

View page
US Patent:
20150073011, Mar 12, 2015
Filed:
Apr 2, 2013
Appl. No.:
14/389854
Inventors:
- Sodertalje, SE
Shanta Bist - Waltham MA, US
Neil Bifulco - Waltham MA, US
Liang Zhao - Waltham MA, US
Ye Wu - Waltham MA, US
Hoan Huynh - Waltham MA, US
Hui Xiong - Waltham MA, US
Janelle Comita-Prevoir - Waltham MA, US
Daemian Dussault - Waltham MA, US
Bolin Geng - Waltham MA, US
Brendan Chen - Waltham MA, US
Thomas Durand-Reville - Waltham MA, US
Satenig Guler - Waltham MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
C07D 471/08
US Classification:
514300, 546121
Abstract:
The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia):or a pharmaceutically acceptable salt thereof, wherein the values of R, R, Rand Rare described herein.
Daemian D Dussault from Auburndale, MA, age ~51 Get Report